Chengzhi Shareholding Co Ltd (000990) - Net Assets

Latest as of March 2026: CN¥18.97 Billion CNY ≈ $2.78 Billion USD

Based on the latest financial reports, Chengzhi Shareholding Co Ltd (000990) has net assets worth CN¥18.97 Billion CNY (≈ $2.78 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥28.15 Billion ≈ $4.12 Billion USD) and total liabilities (CN¥9.17 Billion ≈ $1.34 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 000990 asset base for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥18.97 Billion
% of Total Assets 67.41%
Annual Growth Rate 21.08%
5-Year Change 1.16%
10-Year Change 20.35%
Growth Volatility 104.74

Chengzhi Shareholding Co Ltd - Net Assets Trend (1997–2025)

This chart illustrates how Chengzhi Shareholding Co Ltd's net assets have evolved over time, based on quarterly financial data. Check how tangible is Chengzhi Shareholding Co Ltd's equity to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Chengzhi Shareholding Co Ltd (1997–2025)

The table below shows the annual net assets of Chengzhi Shareholding Co Ltd from 1997 to 2025. For live valuation and market cap data, see 000990 market cap overview.

Year Net Assets Change
2025-12-31 CN¥18.68 Billion
≈ $2.73 Billion		 -0.30%
2024-12-31 CN¥18.73 Billion
≈ $2.74 Billion		 +1.46%
2023-12-31 CN¥18.46 Billion
≈ $2.70 Billion		 -0.27%
2022-12-31 CN¥18.51 Billion
≈ $2.71 Billion		 +0.27%
2021-12-31 CN¥18.46 Billion
≈ $2.70 Billion		 +10.57%
2020-12-31 CN¥16.70 Billion
≈ $2.44 Billion		 +2.16%
2019-12-31 CN¥16.34 Billion
≈ $2.39 Billion		 +0.13%
2018-12-31 CN¥16.32 Billion
≈ $2.39 Billion		 +1.60%
2017-12-31 CN¥16.07 Billion
≈ $2.35 Billion		 +3.53%
2016-12-31 CN¥15.52 Billion
≈ $2.27 Billion		 +491.62%
2015-12-31 CN¥2.62 Billion
≈ $383.83 Million		 +11.99%
2014-12-31 CN¥2.34 Billion
≈ $342.75 Million		 +38.31%
2013-12-31 CN¥1.69 Billion
≈ $247.82 Million		 +2.61%
2012-12-31 CN¥1.65 Billion
≈ $241.51 Million		 -0.35%
2011-12-31 CN¥1.66 Billion
≈ $242.36 Million		 +1.54%
2010-12-31 CN¥1.63 Billion
≈ $238.68 Million		 -2.49%
2009-12-31 CN¥1.67 Billion
≈ $244.78 Million		 +24.35%
2008-12-31 CN¥1.35 Billion
≈ $196.85 Million		 +31.41%
2007-12-31 CN¥1.02 Billion
≈ $149.80 Million		 +2.60%
2006-12-31 CN¥997.75 Million
≈ $146.00 Million		 +2.26%
2005-12-31 CN¥975.70 Million
≈ $142.78 Million		 +4.90%
2004-12-31 CN¥930.16 Million
≈ $136.11 Million		 +10.79%
2003-12-31 CN¥839.58 Million
≈ $122.86 Million		 +7.10%
2002-12-31 CN¥783.92 Million
≈ $114.71 Million		 +8.94%
2001-12-31 CN¥719.56 Million
≈ $105.29 Million		 +8.44%
2000-12-31 CN¥663.54 Million
≈ $97.10 Million		 +313.36%
1999-12-31 CN¥160.52 Million
≈ $23.49 Million		 +24.37%
1998-12-31 CN¥129.07 Million
≈ $18.89 Million		 +46.42%
1997-12-31 CN¥88.15 Million
≈ $12.90 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Chengzhi Shareholding Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 343045588629.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings CN¥3.43 Billion 19.38%
Other Components CN¥14.27 Billion 80.62%
Total Equity CN¥17.70 Billion 100.00%

Chengzhi Shareholding Co Ltd Competitors by Market Cap

The table below lists competitors of Chengzhi Shareholding Co Ltd ranked by their market capitalization.

Company Market Cap
Modern Times Group Mtg AB
ST:MTG-B
 $1.64 Billion
Clover Health Investments Corp
NASDAQ:CLOV
 $1.64 Billion
Ourpalm
SHE:300315
 $1.64 Billion
Companhia Siderúrgica Nacional
MX:SIDN
 $1.64 Billion
IMAX Corporation
F:IMA
 $1.64 Billion
Hyundai Elevator
KO:017800
 $1.64 Billion
Global Partners LP
NYSE:GLP
 $1.64 Billion
Walker & Dunlop Inc
NYSE:WD
 $1.64 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Chengzhi Shareholding Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 17,832,498,223 to 17,697,440,739, a change of -135,057,484 (-0.8%).
  • Net loss of 78,142,676 reduced equity.
  • Dividend payments of 221,139,834 reduced retained earnings.
  • Other comprehensive income decreased equity by 588,096,514.
  • Other factors increased equity by 752,321,540.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥-78.14 Million -0.44%
Dividends Paid CN¥221.14 Million -1.25%
Other Comprehensive Income CN¥-588.10 Million -3.32%
Other Changes CN¥752.32 Million +4.25%
Total Change CN¥- -0.76%

Book Value vs Market Value Analysis

This analysis compares Chengzhi Shareholding Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.63x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 17.27x to 0.63x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1997-12-31 CN¥0.53 CN¥9.22 x
1998-12-31 CN¥0.76 CN¥9.22 x
1999-12-31 CN¥0.95 CN¥9.22 x
2000-12-31 CN¥4.24 CN¥9.22 x
2001-12-31 CN¥4.45 CN¥9.22 x
2002-12-31 CN¥4.74 CN¥9.22 x
2003-12-31 CN¥5.12 CN¥9.22 x
2004-12-31 CN¥5.38 CN¥9.22 x
2005-12-31 CN¥5.63 CN¥9.22 x
2006-12-31 CN¥3.59 CN¥9.22 x
2007-12-31 CN¥3.75 CN¥9.22 x
2008-12-31 CN¥4.75 CN¥9.22 x
2009-12-31 CN¥5.51 CN¥9.22 x
2010-12-31 CN¥5.31 CN¥9.22 x
2011-12-31 CN¥5.39 CN¥9.22 x
2012-12-31 CN¥5.43 CN¥9.22 x
2013-12-31 CN¥5.57 CN¥9.22 x
2014-12-31 CN¥7.25 CN¥9.22 x
2015-12-31 CN¥6.35 CN¥9.22 x
2016-12-31 CN¥39.45 CN¥9.22 x
2017-12-31 CN¥12.69 CN¥9.22 x
2018-12-31 CN¥12.91 CN¥9.22 x
2019-12-31 CN¥13.28 CN¥9.22 x
2020-12-31 CN¥13.57 CN¥9.22 x
2021-12-31 CN¥14.53 CN¥9.22 x
2022-12-31 CN¥14.54 CN¥9.22 x
2023-12-31 CN¥14.53 CN¥9.22 x
2024-12-31 CN¥14.67 CN¥9.22 x
2025-12-31 CN¥14.56 CN¥9.22 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Chengzhi Shareholding Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -0.44%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -0.71%
  • • Asset Turnover: 0.40x
  • • Equity Multiplier: 1.57x
  • Recent ROE (-0.44%) is below the historical average (5.62%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 25.29% 8.93% 1.52x 1.86x CN¥12.22 Million
1998 20.51% 10.00% 1.09x 1.89x CN¥11.92 Million
1999 19.90% 14.07% 0.75x 1.90x CN¥14.01 Million
2000 6.37% 14.73% 0.35x 1.24x CN¥-23.02 Million
2001 6.77% 10.27% 0.48x 1.39x CN¥-21.48 Million
2002 7.79% 6.82% 0.58x 1.99x CN¥-15.68 Million
2003 7.31% 3.85% 0.91x 2.08x CN¥-20.58 Million
2004 5.96% 4.30% 0.67x 2.08x CN¥-32.50 Million
2005 5.91% 3.55% 0.73x 2.27x CN¥-34.50 Million
2006 5.87% 3.61% 0.63x 2.57x CN¥-35.77 Million
2007 5.62% 2.58% 0.87x 2.49x CN¥-39.71 Million
2008 2.23% 1.09% 0.88x 2.31x CN¥-95.81 Million
2009 2.58% 1.43% 0.77x 2.35x CN¥-116.88 Million
2010 1.37% 0.69% 0.89x 2.26x CN¥-135.21 Million
2011 1.98% 1.06% 0.89x 2.10x CN¥-127.93 Million
2012 1.69% 0.81% 1.12x 1.89x CN¥-133.58 Million
2013 3.14% 1.30% 1.20x 2.02x CN¥-113.17 Million
2014 3.16% 1.83% 1.02x 1.69x CN¥-158.62 Million
2015 5.67% 3.41% 0.82x 2.03x CN¥-105.42 Million
2016 0.72% 4.30% 0.13x 1.32x CN¥-1.42 Billion
2017 5.08% 14.20% 0.27x 1.32x CN¥-781.83 Million
2018 5.25% 14.47% 0.25x 1.45x CN¥-768.65 Million
2019 2.74% 6.40% 0.29x 1.49x CN¥-1.17 Billion
2020 2.15% 3.65% 0.40x 1.48x CN¥-1.29 Billion
2021 5.71% 8.28% 0.50x 1.38x CN¥-756.73 Million
2022 0.29% 0.43% 0.48x 1.39x CN¥-1.72 Billion
2023 1.01% 1.43% 0.48x 1.46x CN¥-1.59 Billion
2024 1.29% 2.08% 0.41x 1.52x CN¥-1.55 Billion
2025 -0.44% -0.71% 0.40x 1.57x CN¥-1.85 Billion

Industry Comparison

This section compares Chengzhi Shareholding Co Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $1,054,407,059
  • Average return on equity (ROE) among peers: -13.64%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Chengzhi Shareholding Co Ltd (000990) CN¥18.97 Billion 25.29% 0.48x $1.64 Billion
Shenzhen CAU Technology Co Ltd (000004) $72.91 Million -180.40% 3.27x $9.88 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403) $351.68 Million 19.98% 2.38x $1.33 Billion
Nanhua Bio Medicine Co Ltd (000504) $110.32 Million -17.34% 4.98x $385.38 Million
Jiangsu Sihuan Bioengineering Co Ltd (000518) $611.10 Million 0.73% 0.66x $537.84 Million
Hualan Biological EngineeringInc (002007) $550.80 Million 9.54% 0.27x $3.53 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030) $1.94 Billion 5.22% 0.57x $1.05 Billion
Shanghai RAAS Blood Products Co Ltd Class A (002252) $231.70 Million 22.12% 0.44x $4.99 Billion
Baolingbao Biology Co Ltd (002286) $1.51 Billion 3.27% 0.28x $418.78 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) $4.11 Billion 14.16% 0.65x $1.76 Billion

About Chengzhi Shareholding Co Ltd

SHE:000990 China Biotechnology
Market Cap
$1.64 Billion
CN¥11.20 Billion CNY
Market Cap Rank
#6774 Global
#1361 in China
Share Price
CN¥9.22
Change (1 day)
-0.32%
52-Week Range
CN¥7.24 - CN¥13.17
All Time High
CN¥30.90
Categories
Companies in China Biotechnology
About

Chengzhi Co., Ltd. engages in the clean energy, semiconductor display material, and healthcare and life science businesses in China. The company produces and sells gas products, including carbon monoxide, purified gas, and syngas, as well as industrial chemical products, such as methanol, ethylene, and butanol. It also processes materials comprising TN type, STN type, and TFT type; and glass proc… Read more